Advertisement

Cancer and Metastasis Reviews

, Volume 37, Issue 4, pp 677–690 | Cite as

Cancers of the eye

  • Abhilasha Maheshwari
  • Paul T. FingerEmail author
Article

Abstract

Ocular cancers are unique among the diseases of the eye, threatening both vision and life. In most cases, the diagnosis can be made utilizing a careful clinical history and specialized ocular examination. Eye cancer diagnosis relies heavily on imaging techniques such as high-frequency ultrasound, fluorescein angiography, anterior and posterior segment optical coherence tomography, computed tomography (CT), and magnetic resonance imaging (MRI). Once the diagnosis is established, treatment decisions depend on the tumor’s location, size, local extension, patterns of growth, and secondary complications. Treatment options include observation, local resection, chemotherapy (topical, intravenous, intra-arterial, or intravitreal), and radiation (ophthalmic plaque or external beam). Enucleation or exenteration is only employed if these eye- and vision-sparing treatments are not possible. The core of this comprehensive review is a consecutive series of the most common ocular tumor of each structure of the eye, anterior to posterior, including basal cell carcinoma of the eyelid, squamous conjunctival neoplasia, choroidal melanoma, retinoblastoma, ocular adnexal lymphoma, and metastatic orbital tumors.

Keywords

Basal cell carcinoma Ocular surface squamous neoplasia Choroidal melanoma Retinoblastoma Ocular adnexal lymphoma Metastasis 

Notes

Funding

This study was supported by The Eye Cancer Foundation, Inc. Dr. Maheshwari received a fellowship grant from The Eye Cancer Foundation (http://eyecancercure.com).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Margo, C. E., & Waltz, K. (1993). Basal cell carcinoma of the eyelid and periocular skin. Survey of Ophthalmology, 38(2), 169–192.Google Scholar
  2. 2.
    Esmaeli, B., Dutton, J. J., Graue, G. F., et al. (2016). Eyelid carcinoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 779–785). New York: Springer International Publishing.Google Scholar
  3. 3.
    Bakis, S., Irwig, L., Wood, G., & Wong, D. (2004). Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis. The British Journal of Dermatology, 150(5), 829–836.Google Scholar
  4. 4.
    Cook, B. E., & Bartley, G. B. (2001). Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology, 108(11), 2088–2098.Google Scholar
  5. 5.
    Kokoszka, A., & Scheinfeld, N. (2003). Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et al.], 29(6), 566–571.Google Scholar
  6. 6.
    Lindgren, G., & Larkö, O. (1997). Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. Journal of the American Academy of Dermatology, 36(5 Pt 1), 742–746.Google Scholar
  7. 7.
    Tuppurainen, K. (1995). Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie, 233(4), 205–208.Google Scholar
  8. 8.
    Hughes, W. L. (1986). Reconstructive surgery of the eyelids. Advances in Ophthalmic Plastic and Reconstructive Surgery, 5, 25–87.PubMedGoogle Scholar
  9. 9.
    Kopecky, A., Koch, K. R., Bucher, F., Cursiefen, C., & Heindl, L. M. (2016). Results of Cutler-Beard procedure for reconstruction of extensive full thickness upper eyelid defects following tumor resection. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 113(4), 309–313.Google Scholar
  10. 10.
    Belmajdoub, M., Jacomet, P.-V., Benillouche, P., & Galatoire, O. (2015). Upper eyelid reconstruction with the Cutler-Beard flap technique: retrospective study of 16 cases. Journal Français d'Ophtalmologie, 38(7), 607–614.Google Scholar
  11. 11.
    Leibovitch, I., McNab, A., Sullivan, T., Davis, G., & Selva, D. (2005). Orbital invasion by periocular basal cell carcinoma. Ophthalmology, 112(4), 717–723.Google Scholar
  12. 12.
    Karabulut, G. O., Kaynak, P., Ozturker, C., Fazil, K., Ocak, O. B., & Taskapılı, M. (2017). Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian Journal of Ophthalmology, 65(1), 48–51.Google Scholar
  13. 13.
    de Macedo, E. M. S., Carneiro, R. C., de Lima, P. P., Silva, B. G., & Matayoshi, S. (2015). Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC Ophthalmology, 15, 35.Google Scholar
  14. 14.
    Macha, M. A., Batra, S. K., & Ganti, A. K. (2013). Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. Cancer Management and Research, 5, 197–203.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Ozgur, O. K., Yin, V., Chou, E., Ball, S., Kies, M., William, W. N., Migden, M., Thuro, B. A., & Esmaeli, B. (2015). Hedgehog pathway inhibition for locally advanced periocular basal cell carcinoma and basal cell nevus syndrome. American Journal of Ophthalmology, 160(2), 220–227.Google Scholar
  16. 16.
    Jefford, M., Kiffer, J. D., Somers, G., Daniel, F. J., & Davis, I. D. (2004). Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ Journal of Surgery, 74(8), 704–705.Google Scholar
  17. 17.
    Lee, G. A., & Hirst, L. W. (1995). Ocular surface squamous neoplasia. Survey of Ophthalmology, 39(6), 429–450.Google Scholar
  18. 18.
    Sun, E. C., Fears, T. R., & Goedert, J. J. (1997). Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 6(2), 73–77.Google Scholar
  19. 19.
    Lee, G. A., & Hirst, L. W. (1992). Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Archives of Ophthalmology (Chicago, III.: 1960), 110(4), 525–527.Google Scholar
  20. 20.
    Char, D. H., Crawford, J. B., Howes, E. L., & Weinstein, A. J. (1992). Resection of intraocular squamous cell carcinoma. The British Journal of Ophthalmology, 76(2), 123–125.Google Scholar
  21. 21.
    Semenova, E. A., Milman, T., Finger, P. T., Natesh, S., Kurli, M., Schneider, S., Iacob, C. E., & McCormick, S. A. (2009). The diagnostic value of exfoliative cytology vs histopathology for ocular surface squamous neoplasia. American Journal of Ophthalmology, 148(5), 772–778.Google Scholar
  22. 22.
    Finger, P. T., Tran, H. V., Turbin, R. E., et al. (2003). High-frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma. Archives of Ophthalmology (Chicago, III.: 1960), 121(2), 168–172.Google Scholar
  23. 23.
    Conway, R. M., Graue, G. F., Pelayes, D., et al. (2016). Conjunctival carcinoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 787–793). New York: Springer International Publishing.Google Scholar
  24. 24.
    Finger, P. T. (2005). “Finger-tip” cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. The British Journal of Ophthalmology, 89(8), 942–945.Google Scholar
  25. 25.
    Yousef, Y. A., & Finger, P. T. (2012). Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology, 119(2), 233–240.Google Scholar
  26. 26.
    Chaugule, S. S., Park, J., & Finger, P. T. (2018). Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: is surgery necessary? Indian Journal of Ophthalmology, 66(1), 55.Google Scholar
  27. 27.
    Karp, C. L., Galor, A., Chhabra, S., Barnes, S. D., & Alfonso, E. C. (2010). Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology, 117(12), 2241–2246.Google Scholar
  28. 28.
    Graue, G. F., Tena, L. B., & Finger, P. T. (2011). Electron beam radiation for conjunctival squamous carcinoma. Ophthalmic Plastic and Reconstructive Surgery, 27(4), 277–281.Google Scholar
  29. 29.
    Teng, C. C., Chin, K. J., & Finger, P. T. (2009). Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension. The British Journal of Ophthalmology, 93(6), 837–838.Google Scholar
  30. 30.
    Finger, P. T. (2009). Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Survey of Ophthalmology, 54(5), 545–568.Google Scholar
  31. 31.
    Fraunfelder, F. T., Wallace, T. R., Farris, H. E., et al. (1977). The role of cryosurgery in external ocular and periocular disease. Transactions. Section of Ophthalmology. American Academy of Ophthalmology and Otolaryngology, 83(4 Pt 1), 713–724.Google Scholar
  32. 32.
    Erie, J. C., Campbell, R. J., & Liesegang, T. J. (1986). Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology, 93(2), 176–183.Google Scholar
  33. 33.
    Iliff, W. J., Marback, R., & Green, W. R. (1975). Invasive squamous cell carcinoma of the conjunctiva. Archives of Ophthalmology (Chicago, III.: 1960), 93(2), 119–122.Google Scholar
  34. 34.
    Dimaris, H., Corson, T.W. (2018) Retinoblastoma, the visible CNS tumor: A review. Journal of Neuroscience Research.  https://doi.org/10.1002/jnr.24213.
  35. 35.
    Bishop, J. O., & Madson, E. C. (1975). Retinoblastoma. Review of the current status. Survey of Ophthalmology, 19(6), 342–366.PubMedGoogle Scholar
  36. 36.
    Abramson, D. H., Frank, C. M., Susman, M., Whalen, M. P., Dunkel, I. J., & Boyd, N. W. (1998). Presenting signs of retinoblastoma. The Journal of Pediatrics, 132(3 Pt 1), 505–508.Google Scholar
  37. 37.
    Ainbinder, D. J., Haik, B. G., Frei, D. F., Gupta, K. L., & Mafee, M. F. (1996). Gadolinium enhancement: improved MRI detection of retinoblastoma extension into the optic nerve. Neuroradiology, 38(8), 778–781.Google Scholar
  38. 38.
    Shields, C. L., Fulco, E. M., Arias, J. D., et al. (2013). Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (London, England), 27(2), 253–264.Google Scholar
  39. 39.
    Mallipatna, A. C., Gallie, B. L., Chevez-Barrios, P., et al. (2016). Retinoblastoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 819–831). New York: Springer International Publishing.Google Scholar
  40. 40.
    Shields, C. L., Schoenberg, E., Kocher, K., Shukla, S. Y., Kaliki, S., & Shields, J. A. (2013). Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology, 120(2), 311–316.Google Scholar
  41. 41.
    Karcioglu, Z. A., Gordon, R. A., & Karcioglu, G. L. (1985). Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology, 92(12), 1763–1767.Google Scholar
  42. 42.
    Shields, C. L., Shields, J. A., Cater, J., Othmane, I., Singh, A. D., & Micaily, B. (2001). Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology, 108(11), 2116–2121.Google Scholar
  43. 43.
    Hernandez, J. C., Brady, L. W., Shields, J. A., Shields, C. L., DePotter, P., Karlsson, U. L., Markoe, A. M., Amendola, B. E., & Singh, A. (1996). External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines. International Journal of Radiation Oncology, Biology, Physics, 35(1), 125–132.Google Scholar
  44. 44.
    Honavar, S. G., & Singh, A. D. (2005). Management of advanced retinoblastoma. Ophthalmology Clinics of North America, 18(1), 65–73.Google Scholar
  45. 45.
    Munier, F. L., Gaillard, M.-C., Balmer, A., Soliman, S., Podilsky, G., Moulin, A. P., & Beck-Popovic, M. (2012). Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. The British Journal of Ophthalmology, 96(8), 1078–1083.Google Scholar
  46. 46.
    Shields, C. L., Santos, M. C., Diniz, W., et al. (1999). Thermotherapy for retinoblastoma. Archives of Ophthalmology (Chicago, III.: 1960), 117(7), 885–893.Google Scholar
  47. 47.
    American Brachytherapy Society - Ophthalmic Oncology Task Force., ABS – OOTF Committee. (2014). The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy, 13(1), 1–14.Google Scholar
  48. 48.
    Abramson, D. H., & Frank, C. M. (1998). Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology, 105(4), 573–579 discussion 579-580.Google Scholar
  49. 49.
    Murthy, R., Honavar, S. G., Naik, M. N., & Reddy, V. A. P. (2005). Retinoblastoma. In L. Dutta (Ed.), Modern ophthalmology (Vol. 2, pp. 849–859). New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.Google Scholar
  50. 50.
    Gupta, R., Vemuganti, G. K., Reddy, V. A. P., & Honavar, S. G. (2009). Histopathologic risk factors in retinoblastoma in India. Archives of Pathology & Laboratory Medicine, 133(8), 1210–1214.Google Scholar
  51. 51.
    Finger, P. T., Harbour, J. W., & Karcioglu, Z. A. (2002). Risk factors for metastasis in retinoblastoma. Survey of Ophthalmology, 47(1), 1–16.Google Scholar
  52. 52.
    Gichigo, E. N., Kariuki-Wanyoike, M. M., Kimani, K., & Nentwich, M. M. (2015). Retinoblastoma in Kenya: survival and prognostic factors. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 112(3), 255–260.Google Scholar
  53. 53.
    Singh, A. D., Bergman, L., & Seregard, S. (2005). Uveal melanoma: epidemiologic aspects. Ophthalmology Clinics of North America, 18(1), 75–84 viii.Google Scholar
  54. 54.
    Hu, D.-N., Yu, G.-P., McCormick, S. A., Schneider, S., & Finger, P. T. (2005). Population-based incidence of uveal melanoma in various races and ethnic groups. American Journal of Ophthalmology, 140(4), 612–617.Google Scholar
  55. 55.
    Hawkins, B. S., & Collaborative Ocular Melanoma Study Group. (2004). The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. American Journal of Ophthalmology, 138(6), 936–951.Google Scholar
  56. 56.
    Inskip, P. D., Devesa, S. S., & Fraumeni, J. F. (2003). Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control CCC, 14(3), 251–257.Google Scholar
  57. 57.
    Singh, A. D., & Topham, A. (2003). Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology, 110(5), 956–961.Google Scholar
  58. 58.
    Guénel, P., Laforest, L., Cyr, D., Févotte, J., Sabroe, S., Dufour, C., Lutz, J. M., & Lynge, E. (2001). Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control CCC, 12(5), 451–459.Google Scholar
  59. 59.
    Lutz, J.-M., Cree, I., Sabroe, S., Kvist, T. K., Clausen, L. B., Afonso, N., Ahrens, W., Ballard, T. J., Bell, J., Cyr, D., Eriksson, M., Févotte, J., Guénel, P., Hardell, L., Jöckel, K. H., Miranda, A., Merletti, F., Morales-Suarez-Varela, M. M., Stengrevics, A., & Lynge, E. (2005). Occupational risks for uveal melanoma results from a case-control study in nine European countries. Cancer Causes Control CC, 16(4), 437–447.Google Scholar
  60. 60.
    Vajdic, C. M., Kricker, A., Giblin, M., McKenzie, J., Aitken, J., Giles, G. G., & Armstrong, B. K. (2002). Sun exposure predicts risk of ocular melanoma in Australia. International Journal of Cancer, 101(2), 175–182.Google Scholar
  61. 61.
    Finger, P. T. (2015). Ocular malignancies: choroidal melanoma, retinoblastoma, ocular adnexal lymphoma and eyelid cancer. In B. O’Sullivan & S. H. Huang (Eds.), UICC manual of clinical oncology (pp. 726–745). West Sussex: Wiley.Google Scholar
  62. 62.
    Lemaître, S., Zmuda, M., Jacomet, P. V., Lévy-Gabriel, C., Dendale, R., Berges, O., Fréneaux, P., Mariani, P., Desjardins, L., Galatoire, O., & Cassoux, N. (2017). Small choroidal melanoma revealed by a large extrascleral extension. Ocular Oncology and Pathology, 3(3), 240–246.Google Scholar
  63. 63.
    Lorenzano, D., Miszkiel, K., & Rose, G. E. (2017). Orbital melanoma masquerading as a “galloping haemangioma.”. Orbit (Amsterdam, Netherlands), 36(2), 81–83.Google Scholar
  64. 64.
    Freton, A., Chin, K.J., Raut, R. Tena, L.B.Kivelä, T., Finger, P. T. (2002). Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. European Journal of Ophthalmology, 22(2), 236–243.Google Scholar
  65. 65.
    Augsburger, J. J., & Shields, J. A. (1984). Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques. Ophthalmic Surgery, 15(1), 34–40.PubMedGoogle Scholar
  66. 66.
    Kivela, T., Simpson, E. R., Grossniklaus, H. E., et al. (2016). Uveal melanoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 805–813). New York: Springer International Publishing.Google Scholar
  67. 67.
    Earle, J., Kline, R. W., & Robertson, D. M. (1987). Selection of iodine 125 for the Collaborative Ocular Melanoma Study. Archives of Ophthalmology, 105(6), 763–764.Google Scholar
  68. 68.
    De Potter, P., Shields, C. L., Shields, J. A., Cater, J. R., & Brady, L. W. (1996). Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Archives of Ophthalmology (Chicago, III.: 1960), 114(11), 1357–1365.Google Scholar
  69. 69.
    Finger, P. T., Chin, K. J., & Duvall, G. (2009). Palladium-103 for Choroidal Melanoma Study Group. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology, 116(4), 790–796.Google Scholar
  70. 70.
    Maheshwari, A., Finger, P. T. (2018) A 12-year study of slotted palladium-103 plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve. American Journal of Ophthalmology, 188, 60–69.Google Scholar
  71. 71.
    Chiu-Tsao, S.-T., Astrahan, M. A., Finger, P. T., et al. (2012). Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Medical Physics, 39(10), 6161–6184.Google Scholar
  72. 72.
    Shields, C. L., Shields, J. A., Cater, J., et al. (2000). Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Archives of Ophthalmology (Chicago, III.: 1960), 118(9), 1219–1228.Google Scholar
  73. 73.
    Finger, P. T., Lu, D., Buffa, A., DeBlasio, D. S., & Bosworth, J. L. (1993). Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 27(4), 849–854.Google Scholar
  74. 74.
    Gragoudas, E. S., Seddon, J. M., Egan, K., Glynn, R., Munzenrider, J., Austin-Seymour, M., Goitein, M., Verhey, L., Urie, M., & Koehler, A. (1987). Long-term results of proton beam irradiated uveal melanomas. Ophthalmology, 94(4), 349–353.Google Scholar
  75. 75.
    Krema, H., Somani, S., Sahgal, A., Xu, W., Heydarian, M., Payne, D., McGowan, H., Michaels, H., Simpson, E. R., & Laperriere, N. (2009). Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. The British Journal of Ophthalmology, 93(9), 1172–1176.Google Scholar
  76. 76.
    Char, D. H., Bove, R., & Phillips, T. L. (2003). Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. American Journal of Ophthalmology, 136(1), 180–182.Google Scholar
  77. 77.
    Wachtlin, J., Bechrakis, N. E., & Foerster, M. H. (2005). Photodynamic therapy with verteporfin for uveal melanoma. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 102(3), 241–246.Google Scholar
  78. 78.
    Wilson, D. J., & Klein, M. L. (2002). Choroidal melanoma treated with cryotherapy. Archives of Ophthalmology, 120(3), 393–395.PubMedGoogle Scholar
  79. 79.
    Augsburger, J. J., & Gamel, J. W. (1990). Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer, 66(7), 1596–1600.Google Scholar
  80. 80.
    Collaborative Ocular Melanoma Study Group. (2001). Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Archives of Ophthalmology (Chicago, III.: 1960), 119(5), 670–676.Google Scholar
  81. 81.
    Sjö, L. D., Ralfkiaer, E., Prause, J. U., et al. (2008). Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Investigative Ophthalmology & Visual Science, 49(8), 3283–3288.Google Scholar
  82. 82.
    Coupland, S. E., Hellmich, M., Auw-Haedrich, C., Lee, W. R., & Stein, H. (2004). Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie, 242(2), 130–145.Google Scholar
  83. 83.
    Knowles, D. M., Jakobiec, F. A., McNally, L., & Burke, J. S. (1990). Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Human Pathology, 21(9), 959–973.Google Scholar
  84. 84.
    Shields, C. L., Shields, J. A., Carvalho, C., Rundle, P., & Smith, A. F. (2001). Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology, 108(5), 979–984.Google Scholar
  85. 85.
    Heegaard, S., Chevez-Barrios, P., White, V. A., Coupland, S. E., & Finger, P. T. (2016). Ocular adnexal lymphoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 849–854). New York: Springer International Publishing.Google Scholar
  86. 86.
    Hepler, R. S. (1972). Clinical diagnosis of orbital tumors. Radiologic Clinics of North America, 10(1), 3–10.PubMedGoogle Scholar
  87. 87.
    Gerbino, G., Boffano, P., Benech, R., et al. (2014). Orbital lymphomas: clinical and radiological features. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery, 42(5), 508–512.Google Scholar
  88. 88.
    Coupland, S. E., Krause, L., Delecluse, H. J., et al. (1998). Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology, 105(8), 1430–1441.Google Scholar
  89. 89.
    English, J. F., & Sullivan, T. J. (2015). The role of FDG-PET in the diagnosis and staging of ocular adnexal lymphoproliferative disease. Orbit (Amsterdam, Netherlands), 34(5), 284–291.Google Scholar
  90. 90.
    Hui, K.-H., Pfeiffer, M. L., & Esmaeli, B. (2012). Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society, 26(4), 365–371.Google Scholar
  91. 91.
    Fung, C. Y., Tarbell, N. J., Lucarelli, M. J., Goldberg, S. I., Linggood, R. M., Harris, N. L., & Ferry, J. A. (2003). Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. International Journal of Radiation Oncology, Biology, Physics, 57(5), 1382–1391.Google Scholar
  92. 92.
    Leget, G. A., & Czuczman, M. S. (1998). Use of rituximab, the new FDA-approved antibody. Current Opinion in Oncology, 10(6), 548–551.Google Scholar
  93. 93.
    Maloney, D. G., Grillo-López, A. J., White, C. A., et al. (1997). IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood, 90(6), 2188–2195.PubMedGoogle Scholar
  94. 94.
    McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., Jain, V., Ho, A. D., Lister, J., Wey, K., Shen, D., & Dallaire, B. K. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(8), 2825–2833.Google Scholar
  95. 95.
    Chan, C.-C., Smith, J. A., Shen, D. F., Ursea, R., LeHoang, P., & Grossniklaus, H. E. (2004). Helicobacter pylori (H. pylori) molecular signature in conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Histology and Histopathology, 19(4), 1219–1226.PubMedPubMedCentralGoogle Scholar
  96. 96.
    Ferreri, A. J. M., Guidoboni, M., Ponzoni, M., de Conciliis, C., Dell'Oro, S., Fleischhauer, K., Caggiari, L., Lettini, A. A., Dal Cin, E., Ieri, R., Freschi, M., Villa, E., Boiocchi, M., & Dolcetti, R. (2004). Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. Journal of the National Cancer Institute, 96(8), 586–594.Google Scholar
  97. 97.
    Kirkegaard, M. M., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Prause, J. U., Ralfkiaer, E., Sjö, L. D., Toft, P. B., Vemuganti, G. K., Thuro, B. A., Curtin, J., & Heegaard, S. (2016). Conjunctival lymphoma—an international multicenter retrospective study. JAMA Ophthalmology, 134(4), 406–414.Google Scholar
  98. 98.
    Rasmussen, P. K., Coupland, S. E., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., McKelvie, P., Mulay, K., Prause, J. U., Ralfkiaer, E., Sjö, L. D., & Heegaard, S. (2014). Ocular adnexal follicular lymphoma: a multicenter international study. JAMA Ophthalmology, 132(7), 851–858.Google Scholar
  99. 99.
    Svendsen, F. H., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Ralfkiaer, E., Sjö, L. D., Vemuganti, G. K., Thuro, B. A., Curtin, J., & Heegaard, S. (2017). Lymphoma of the eyelid—an international multicenter retrospective study. American Journal of Ophthalmology, 177, 58–68.Google Scholar
  100. 100.
    Jenkins, C., Rose, G. E., Bunce, C., et al. (2000). Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. The British Journal of Ophthalmology, 84(8), 907–913.Google Scholar
  101. 101.
    McKelvie, P. A., McNab, A., Francis, I. C., Fox, R., & O’Day, J. (2001). Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clinical & Experimental Ophthalmology, 29(6), 387–393.Google Scholar
  102. 102.
    Char, D. H., Miller, T., & Kroll, S. (1997). Orbital metastases: diagnosis and course. The British Journal of Ophthalmology, 81(5), 386–390.Google Scholar
  103. 103.
    Ferry, A. P., & Font, R. L. (1974). Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Archives of Ophthalmology (Chicago, III.: 1960), 92(4), 276–286.Google Scholar
  104. 104.
    Kennedy, R. E. (1984). An evaluation of 820 orbital cases. Transactions of the American Ophthalmological Society, 82, 134–157.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Shields, J. A., Bakewell, B., Augsburger, J. J., & Flanagan, J. C. (1984). Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Archives of Ophthalmology (Chicago, III.: 1960), 102(11), 1606–1611.Google Scholar
  106. 106.
    Goldberg, R. A., Rootman, J., & Cline, R. A. (1990). Tumors metastatic to the orbit: a changing picture. Survey of Ophthalmology, 35(1), 1–24.Google Scholar
  107. 107.
    Günalp, I., & Gündüz, K. (1995). Metastatic orbital tumors. Japanese Journal of Ophthalmology, 39(1), 65–70.PubMedGoogle Scholar
  108. 108.
    Shields, C. L., Shields, J. A., & Peggs, M. (1988). Tumors metastatic to the orbit. Ophthalmic Plastic and Reconstructive Surgery, 4(2), 73–80.Google Scholar
  109. 109.
    Shields, J. A., Shields, C. L., Brotman, H. K., Carvalho, C., Perez, N., & Eagle, R. C. (2001). Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthalmic Plastic and Reconstructive Surgery, 17(5), 346–354.Google Scholar
  110. 110.
    Bersani, T. A., Costello, J. J., Mango, C. A., & Streeten, B. W. (1994). Benign approach to a malignant orbital tumor: metastatic renal cell carcinoma. Ophthalmic Plastic and Reconstructive Surgery, 10(1), 42–44.Google Scholar
  111. 111.
    Betharia, S. M. (1985). Metastatic orbital carcinoma of thyroid. Indian Journal of Ophthalmology, 33(3), 191–193.PubMedGoogle Scholar
  112. 112.
    Drake, E. T., & Dobben, G. D. (1959). Leiomyosarcoma of the uterus with unusual metastases. Journal of the American Medical Association, 170(11), 1294–1298.Google Scholar
  113. 113.
    Rush, J. A., Older, J. J., & Richman, A. V. (1981). Testicular seminoma metastatic to the orbit. American Journal of Ophthalmology, 91(2), 258–260.Google Scholar
  114. 114.
    Saxena, R. B., Mathur, R. N., & Sonani, S. Z. (1975). Orbital metastasis of mixed parotid tumour. Indian Journal of Ophthalmology, 23(2), 23–24.PubMedGoogle Scholar
  115. 115.
    Seretan, E. L. (1981). Metastatic adenocarcinoma from the stomach to the orbit. Archives of Ophthalmology (Chicago, III.: 1960), 99(8), 1469.Google Scholar
  116. 116.
    Smiley, S. S. (1965). An orbital metastasis from the urinary bladder. Archives of Ophthalmology (Chicago, III.: 1960), 74(6), 809–810.Google Scholar
  117. 117.
    Stewart, W. B., Newman, N. M., Cavender, J. C., & Spencer, W. H. (1978). Fibrous histiocytoma metastatic to the orbit. Archives of Ophthalmology (Chicago, III.: 1960), 96(5), 871–873.Google Scholar
  118. 118.
    Healy, J. F. (1983). Computed tomographic evaluation of metatases to the orbit. Annals of Ophthalmology, 15(11), 1026–1029.PubMedGoogle Scholar
  119. 119.
    Hanson, M. W., Schneider, A. M., Enterline, D. S., Feldman, J. M., & Gockerman, J. P. (1998). Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 39(4), 647–650.Google Scholar
  120. 120.
    Glassburn, J. R., Klionsky, M., & Brady, L. W. (1984). Radiation therapy for metastatic disease involving the orbit. American Journal of Clinical Oncology, 7(2), 145–148.Google Scholar
  121. 121.
    Saitoh, A., Amemiya, T., & Tsuda, N. (1997). Metastasis of breast carcinoma to eyelid and orbit of a postmenopausal woman: good response to tamoxifen therapy. Ophthalmologica. Journal International D’ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, 211(6), 362–366.Google Scholar
  122. 122.
    Kuo, S.-C., Hsiao, S.-C., Chiou, C.-C., Chen, F.-F., & Huang, K.-C. (2008). Metastatic carcinoma of the breast: a case with the unusual presentation of unilateral periorbital edema. Japanese Journal of Ophthalmology, 52(4), 305–307.Google Scholar
  123. 123.
    Carriere, V. M., Karcioglu, Z. A., Apple, D. J., & Insler, M. S. (1982). A case of prostate carcinoma with bilateral orbital metastases and the review of the literature. Ophthalmology, 89(4), 402–406.Google Scholar
  124. 124.
    Kopelman, J. E., & Shorr, N. (1987). A case of prostatic carcinoma metastatic to the orbit diagnosed by fine needle aspiration and immunoperoxidase staining for prostatic specific antigen. Ophthalmic Surgery, 18(8), 599–603.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.The New York Eye Cancer CenterNew YorkUSA

Personalised recommendations